REQUEST A DEMO
Total
USD $0.00
Search more companies

Sengenics Sdn. Bhd. (Malaysia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Sengenics Sdn. Bhd. Profile Updated: February 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Engaging in the business of commercialization of cytogenetic and molecular diagnostic product and services and to undertake its related research and development activities.

Headquarters
Mezzanine Floor, Block A, Plaza Zurich, No.12, Jalan Gelanggang, Bukit Damansara
Kuala Lumpur; Federal Territories; Postal Code: 50490

Contact Details: Purchase the Sengenics Sdn. Bhd. report to view the information.

Website: http://www.sengenics.com

Basic Information
Outstanding Shares:
Purchase the Sengenics Sdn. Bhd. report to view the information.
Registered Capital:
Purchase the Sengenics Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Sengenics Sdn. Bhd. report to view the information.
Incorporation Date:
July 03, 2008
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Sengenics Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
22.05%
Total operating revenue
22.05%
Operating profit (EBIT)
-20.64%
Net Profit (Loss) for the Period
-20.64%
Total assets
5.4%
Total equity
-273.93%
Operating Profit Margin (ROS)
1.05%
Net Profit Margin
1.05%
Return on Equity (ROE)
-141.34%
Quick Ratio
-0.13%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?